Zhang et al revealed that down-regulated CCAT2 expression combined with Wnt signaling inhibitor FH 535 which affecting the nuclear accumulation of β-catenin thus attenuated Wnt/β-catenin signaling transcriptional activity in breast cancer. This evidence concerns the gene CCAT2 and breast cancer.